New therapy strategies in secondary hyperparathyroidism on dialysis (I): new concepts, new treatments

Secondary hyperparathyroidism (SHP) is still an early and frequent complication of chronic renal disease (CRD). Currently, CRD is an independent cardiovascular risk factor, and calcium-phosphorus metabolism is one of the modifiable related factors. In this first article, we summarize the recent SHP...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Nefrología 2005, Vol.25 Suppl 2, p.100-108
Hauptverfasser:	Bover, J, Ortiz-Herbener, F, Ballarín, J, Andrés, E, Barceló, P
Format:	Artikel
Sprache:	spa
Schlagworte:	Algorithms Bile Acids and Salts - administration & dosage Bile Acids and Salts - therapeutic use Calcium - administration & dosage Calcium - metabolism Calcium - therapeutic use Cardiovascular Diseases - etiology Cardiovascular Diseases - prevention & control Disease Progression Drug Therapy, Combination Epoxy Compounds - administration & dosage Epoxy Compounds - therapeutic use Female Ferric Compounds - administration & dosage Ferric Compounds - therapeutic use Humans Hyperparathyroidism, Secondary - etiology Hyperparathyroidism, Secondary - therapy Kidney Failure, Chronic - complications Kidney Failure, Chronic - therapy Lanthanum - administration & dosage Lanthanum - therapeutic use Male Multivariate Analysis Niacinamide - administration & dosage Niacinamide - therapeutic use Phosphate-Binding Proteins - therapeutic use Phosphates - blood Phosphates - metabolism Phosphorus - metabolism Polyamines Polyethylenes - administration & dosage Polyethylenes - therapeutic use Practice Guidelines as Topic Randomized Controlled Trials as Topic Renal Dialysis - adverse effects Risk Factors Sevelamer Time Factors
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!